Palbociclib T1785
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Palbociclib is an orally available cyclin-dependent kinase (CDK) inhibitor with potential antineoplastic activity. Palbociclib selectively inhibits cyclin-dependent kinase 4 (CDK4) and 6 (CDK6), thereby inhibiting retinoblastoma (Rb) protein phosphorylati
CAS nr:
571190-30-2
Purity:
98%
Molecular Weight:
447,54
SMILES:
c1(nc2c(cn1)c(c(c(=O)n2C1CCCC1)C(=O)C)C)Nc1ccc(cn1)N1CCNCC1
Formula:
C24H29N7O2
Pathway:
Cell Cycle/Checkpoint
Target:
CDK
